Shifting cost dynamics and infrastructure capabilities are prompting manufacturers to reassess traditional distribution channels.
Jay Bregman
Advertisement
Jay Bregman is the founder and CEO of Andel.
Articles by Jay Bregman
Jay Bregman, founder and CEO of Andel, discusses how employers are managing rising costs for prescription benefits and how pharma companies are shifting their distribution patterns.
In the first part of his Pharmaceutical Commerce interview, Jay Bregman, founder and CEO of Andel, discusses how employers are exploring direct-to-employer drug purchasing models that bypass traditional pathways.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Seven Companies Selected for FDA Pilot to Strengthen US Drug Supply Chain
2
The Hidden Architecture of Drug Shortages: Why Inventory Economics Determine Patient Access
3
Q&A: What It Will Take to Scale CGT Supply Chains
4
Gerren McHam: What Effective Pharma Reshoring Actually Requires
5